The ninth annual Precision Medicine World Conference (PMWC) 2018-Silicon Valley opened on Monday, Janaury 22, at the Computer History Museum in Mountain View, Calfornia. This year’s premier three-day event is expected to attract almost 1,500 attendees and will feature over 350 speakers, 250 companies, and scores of exhibitors. The meeting is organized by Tal Behar and her husband Gadi Behar. Monday’s official opening was preceded by a special awards ceremony Sunday evening at which four highly distinguished scientists were presented with special awards. The PMWC 2018 Luminary Award was presented to Emmanuelle Charpentier, PhD, for spearheading the development of the groundbreaking CRISPR-Cas9 genome editing technology. With this award, the PMWC recognizes recent contributions of preeminent figures who have accelerated personalized medicine into the clinical marketplace. The PMWC 2018 Pioneer Awards were presented to Alan Ashworth, PhD, for co-discovering the BRCA2 gene mutation and making discoveries leading to PARP inhibition in breast and other cancers; to Professor Sir John Bell (photo), of Oxford University, for leading genetic and genomic research initiatives that enable precision medicine in the UK and globally; and to Ronald Levy, MD, for developing the first FDA-approved antibody for the treatment of cancer (rituximab). With its Pioneer Awards, the PMWC recognizes rare individuals who have presaged the advent of personalized medicine when less evolved technology and encouragement from peers existed, but still made major advances in the field. Previous PMWC award recipients include Jennifer Douda, Lee Hood, George Church, and Francis Collins. Day One of PMWC 2018 was divided into five parallel tracks focusing on areas crucial for precision medicine.
Login Or Register To Read Full Story